Market validation

FDA Regulatory Change Monitor

A proposed public regulatory data feed for product, compliance, and research teams tracking recalls, enforcement reports, clinical-trial status changes, and adverse event dataset changes. It is data infrastructure only.

Request this feed View current demo Open paid API

GET /v1/regulatory/fda/changes?dataset=enforcement&product=medical-device&since=2026-07-01

{
  "data": [
    {
      "recordId": "sample-fda-2026-001",
      "dataset": "enforcement",
      "classification": "Class II",
      "productType": "medical-device",
      "reportedAt": "2026-07-02"
    }
  ],
  "meta": { "sampleOnly": true, "market": "fda-regulatory" }
}

Validation Thesis

This concept is only built further if tracked requests, demo clicks, or marketplace intent justify the build.

Recall and enforcement monitoring for operations workflows.
Dataset change feed for analysts and health-data applications.
Strictly public data, with no diagnosis, treatment, or safety advice.

Public Data Sources

The initial product would normalize public records into stable polling endpoints and exports.

openFDA public APIs
ClinicalTrials.gov public data API

Buyer Workflows

These are the specific self-serve workflows this page is testing before any backend is built.

Recall change monitoring

Poll public recall and enforcement datasets for new records that match a product category or company name.

Regulatory dataset deltas

Track public FDA dataset updates as normalized change records for research and compliance dashboards.

Trial-status watchlists

Monitor public clinical-trial records for status, sponsor, condition, or intervention changes.

Specific Workflow Tests

These pages test sharper buyer searches before implementation.

Workflow validation FDA Recall API Public FDA recall and enforcement change monitoring Workflow validation Clinical Trial Change API Clinical trial status and sponsor change monitoring

Monetization Hypothesis

Pricing only becomes meaningful after tracked demand appears. The first offer should stay narrow and low-touch.

Validation-first pricing only after recall/feed demand is proven
Separate higher tier for trial-change watchlists if requested
No medical advice, diagnosis, safety, or efficacy recommendations

Validation FAQ

Is this a medical advice product?

No. The concept is public regulatory data infrastructure only and would avoid diagnosis, treatment, or safety guidance.

Why validate before building this market?

The compliance risk and buyer specificity are higher, so tracked intent should lead implementation.